Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab due to side effects

    Risultato della ricerca: Article

    Lingua originaleUndefined/Unknown
    pagine (da-a)249-252
    RivistaAnnals of the Rheumatic Diseases
    Volume66
    Stato di pubblicazionePublished - 2007

    Cita questo

    @article{6fde506c9592462b80810e7fa2ced2eb,
    title = "Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab due to side effects",
    author = "Giovanni Triolo",
    year = "2007",
    language = "Undefined/Unknown",
    volume = "66",
    pages = "249--252",
    journal = "Annals of the Rheumatic Diseases",
    issn = "0003-4967",
    publisher = "BMJ Publishing Group",

    }

    TY - JOUR

    T1 - Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab due to side effects

    AU - Triolo, Giovanni

    PY - 2007

    Y1 - 2007

    UR - http://hdl.handle.net/10447/31955

    M3 - Article

    VL - 66

    SP - 249

    EP - 252

    JO - Annals of the Rheumatic Diseases

    JF - Annals of the Rheumatic Diseases

    SN - 0003-4967

    ER -